Bessemer Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5K | Sell |
151
-141
| -48% | -$4.67K | ﹤0.01% | 2044 |
|
2025
Q1 | $10K | Sell |
292
-111
| -28% | -$3.8K | ﹤0.01% | 1788 |
|
2024
Q4 | $14K | Buy |
403
+141
| +54% | +$4.9K | ﹤0.01% | 1637 |
|
2024
Q3 | $8K | Sell |
262
-60
| -19% | -$1.83K | ﹤0.01% | 1765 |
|
2024
Q2 | $8K | Buy |
322
+231
| +254% | +$5.74K | ﹤0.01% | 1594 |
|
2024
Q1 | $3K | Sell |
91
-129
| -59% | -$4.25K | ﹤0.01% | 1896 |
|
2023
Q4 | $7K | Buy |
220
+50
| +29% | +$1.59K | ﹤0.01% | 1686 |
|
2023
Q3 | $5K | Buy |
170
+17
| +11% | +$500 | ﹤0.01% | 1758 |
|
2023
Q2 | $4K | Buy |
153
+45
| +42% | +$1.18K | ﹤0.01% | 1894 |
|
2023
Q1 | $4K | Sell |
108
-26
| -19% | -$963 | ﹤0.01% | 1707 |
|
2022
Q4 | $5K | Hold |
134
| – | – | ﹤0.01% | 1595 |
|
2022
Q3 | $5K | Hold |
134
| – | – | ﹤0.01% | 1715 |
|
2022
Q2 | $4K | Hold |
134
| – | – | ﹤0.01% | 1628 |
|
2022
Q1 | $4K | Sell |
134
-25
| -16% | -$746 | ﹤0.01% | 1621 |
|
2021
Q4 | $5K | Buy |
+159
| New | +$5K | ﹤0.01% | 1595 |
|
2021
Q1 | – | Sell |
-289
| Closed | -$7K | – | 1657 |
|
2020
Q4 | $7K | Buy |
+289
| New | +$7K | ﹤0.01% | 1344 |
|
2019
Q4 | – | Sell |
-275
| Closed | -$8K | – | 1761 |
|
2019
Q3 | $8K | Buy |
+275
| New | +$8K | ﹤0.01% | 1506 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 1843 |
|
2019
Q1 | – | Sell |
-5,500
| Closed | -$183K | – | 1962 |
|
2018
Q4 | $183K | Hold |
5,500
| – | – | ﹤0.01% | 1002 |
|
2018
Q3 | $277K | Sell |
5,500
-900
| -14% | -$45.3K | ﹤0.01% | 920 |
|
2018
Q2 | $383K | Buy |
+6,400
| New | +$383K | ﹤0.01% | 843 |
|
2016
Q2 | – | Sell |
-38,723
| Closed | -$591K | – | 1447 |
|
2016
Q1 | $591K | Sell |
38,723
-176,424
| -82% | -$2.69M | ﹤0.01% | 532 |
|
2015
Q4 | $2.89M | Buy |
215,147
+38,512
| +22% | +$518K | 0.02% | 359 |
|
2015
Q3 | $2.48M | Buy |
176,635
+161,515
| +1,068% | +$2.27M | 0.01% | 370 |
|
2015
Q2 | $257K | Buy |
+15,120
| New | +$257K | ﹤0.01% | 722 |
|